Astera Labs (NASDAQ:ALAB) Shares Up 1.8% – Still a Buy?

Astera Labs, Inc. (NASDAQ:ALABGet Free Report)’s share price rose 1.8% during mid-day trading on Friday . The company traded as high as $239.77 and last traded at $232.68. Approximately 5,923,016 shares changed hands during mid-day trading, an increase of 10% from the average daily volume of 5,394,691 shares. The stock had previously closed at $228.64.

Key Stories Impacting Astera Labs

Here are the key news stories impacting Astera Labs this week:

  • Positive Sentiment: Northland Securities sharply raised its earnings outlook for Astera Labs (ALAB) across multiple periods, including FY2026, FY2027, and several quarterly estimates, signaling stronger expected profitability ahead.
  • Positive Sentiment: Analyst sentiment is also improving elsewhere, with another report lifting ALAB’s price target to $246.06, reinforcing the view that Wall Street sees more upside in the stock. Astera Labs price target increased by 20.85% to 246.06
  • Positive Sentiment: Zacks highlighted strong UALink 2.0 momentum and Scorpio switch expansion, saying these products are helping drive Astera Labs’ AI infrastructure growth and could support additional upside as deployments build into 2027. ALAB Benefits From Strong UALink Growth: More Upside Ahead?

Analyst Ratings Changes

ALAB has been the subject of a number of research reports. JPMorgan Chase & Co. increased their target price on shares of Astera Labs from $205.00 to $280.00 and gave the stock an “overweight” rating in a research report on Wednesday, May 6th. Rothschild & Co Redburn assumed coverage on shares of Astera Labs in a research report on Friday, May 1st. They issued a “neutral” rating and a $153.00 price target on the stock. Weiss Ratings upgraded shares of Astera Labs from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, May 6th. Morgan Stanley raised their price objective on shares of Astera Labs from $210.00 to $240.00 and gave the stock an “overweight” rating in a report on Wednesday, May 6th. Finally, Citigroup lifted their price objective on shares of Astera Labs from $200.00 to $245.00 and gave the company a “buy” rating in a research note on Wednesday, May 6th. Fifteen research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. According to data from MarketBeat, Astera Labs currently has an average rating of “Moderate Buy” and an average target price of $229.65.

View Our Latest Report on ALAB

Astera Labs Price Performance

The business’s fifty day moving average price is $153.02 and its 200-day moving average price is $155.87. The stock has a market capitalization of $39.88 billion, a PE ratio of 157.22, a P/E/G ratio of 2.97 and a beta of 3.35.

Astera Labs (NASDAQ:ALABGet Free Report) last issued its quarterly earnings data on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, beating the consensus estimate of $0.54 by $0.07. The company had revenue of $308.36 million during the quarter, compared to analysts’ expectations of $292.19 million. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. Astera Labs’s revenue for the quarter was up 93.5% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.33 earnings per share. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, analysts expect that Astera Labs, Inc. will post 1.84 earnings per share for the current fiscal year.

Insider Transactions at Astera Labs

In related news, Director Manuel Alba sold 183,000 shares of Astera Labs stock in a transaction on Wednesday, April 1st. The shares were sold at an average price of $107.61, for a total value of $19,692,630.00. Following the transaction, the director owned 319,863 shares in the company, valued at $34,420,457.43. This trade represents a 36.39% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Michael Truett Tate sold 12,001 shares of the business’s stock in a transaction dated Tuesday, February 17th. The shares were sold at an average price of $123.81, for a total value of $1,485,843.81. Following the completion of the sale, the chief financial officer directly owned 192,083 shares of the company’s stock, valued at approximately $23,781,796.23. This trade represents a 5.88% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 1,497,338 shares of company stock valued at $236,827,957 over the last quarter. 12.50% of the stock is owned by company insiders.

Hedge Funds Weigh In On Astera Labs

A number of hedge funds and other institutional investors have recently made changes to their positions in ALAB. Nordea Investment Management AB purchased a new stake in shares of Astera Labs in the 4th quarter worth about $2,028,000. Geneva Partners LLC purchased a new position in Astera Labs during the 3rd quarter valued at about $1,876,000. Numerai GP LLC boosted its stake in Astera Labs by 153.1% during the third quarter. Numerai GP LLC now owns 13,212 shares of the company’s stock worth $2,587,000 after acquiring an additional 7,992 shares in the last quarter. Handelsbanken Fonder AB boosted its stake in Astera Labs by 289.5% during the third quarter. Handelsbanken Fonder AB now owns 126,200 shares of the company’s stock worth $24,710,000 after acquiring an additional 93,800 shares in the last quarter. Finally, Paragon Advisors LLC purchased a new stake in Astera Labs in the third quarter worth about $1,829,000. Institutional investors own 60.47% of the company’s stock.

Astera Labs Company Profile

(Get Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

See Also

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.